Pages Menu
FacebookTwitterPinterestRss
Categories Menu

Posted by on Jul 2, 2016 in Foundation NewsLine, Type C |

Orphazyme Update – 06/27/2016

orphazyme

The NNPDF Central Office has received the following
press release from Orphazyme with regards to
FDA Grants Fast Track Designation for the
Phase III Clinical Investigation 
of Arimoclomol
as a treatment of Niemann-Pick Disease Type C

Dateline: June 27th, 2016
CLICK HERE FOR THE FULL PRESS RELEASE